Polycystic ovary syndrome (PCOS) is the most common endocrine disorder among
reproductive-aged women. It is characterized by chronic anovulation, hyperandrogenism …

BACKGROUND Despite significant advances in our understanding of the pathophysiology
of preeclampsia (PE), there are still many unknowns and controversies in the field. Women …

Abstract Background Polycystic Ovarian Syndrome (PCOS) is an under-recognized, under-
diagnosed and under-studied disorder; its prevalence varies between 5–26%, 6–10% of …

Objective To compare the efficacy of letrozole and clomiphene citrate (CC) for ovulation
induction in infertile women with polycystic ovarian syndrome (PCOS). Methods In this …

Purpose Clomiphene citrate (CC) has been used as a first‐line treatment for anovulatory
polycystic ovary syndrome (PCOS). However, some patients with PCOS are resistant to …

Background Many studies have documented a lower likelihood of live birth with increasing
body mass index among women undergoing assisted reproductive technology, but few have …

Purpose To assess whether anti-Müllerian hormone (AMH) can predict response to
ovulation induction (OI) with clomiphene citrate (CC), letrozole (LET), or follicle-stimulating …

Research question: Clomiphene citrate (CC) is one of the first-line treatments for ovulation
induction in women with anovulatory polycystic ovary syndrome (PCOS). However, nearly 1 …

Objective: To explore the effects of letrozole (LE) in combination with low-dose intramuscular
injection of human menopausal gonadotropin (HMG) on the ovulation induction and …

Objectives: To compare the efficacy of letrozole (LTZ) vs clomiphene citrate (CC) for
ovulation induction in patients having polycystic ovarian syndrome (PCOS). Methods: This …